HDAC1 and neuroblastoma: Functionally, selective knockdown of HDAC1 sensitized the multi-drug resistant CHLA-136 cell line to etoposide, a topoisomerase II inhibitor commonly used for the treatment of high-risk neuroblastoma (Keshelava et al., 2007).